Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verstraete

Showing results (61-70 of 414) with videos related to

Pageof 42
Sort By:
British Medical Bulletin|October 1, 1994
Primary and secondary prevention of arterial thromboembolismM Verstraete
The American Journal of Medicine|December 1, 1976
Are agents affecting platelet functions clinically useful?M Verstraete
Coronary Artery Disease|April 1, 1994
Thrombolysis for arterial conditions other than myocardial infarctionM Verstraete
Thrombosis and Haemostasis|August 31, 1976
Registry of prospective clinical trials second reportM Verstraete
Acta Clinica Belgica|January 1, 1976
Are agents affecting platelet function clinically useful in patients with coronary artery disease?M Verstraete
Journal of Interventional Cardiology|November 4, 1995
Trials of the European Working Party on streptokinase and of the European Cooperative Study Group on alteplase in patients with acute myocardial infarction. European InvestigatorsM Verstraete
Lancet (London, England)|June 2, 2001
Exit of platelet glycoprotein-IIb/IIIa-receptor inhibitors?M Verstraete
Thrombosis Et Diathesis Haemorrhagica|June 30, 1975
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trialsM Verstraete
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1992
[European vision]M Verstraete
Drugs|June 1, 1978
Antiplatelet agents in coronary disease: are they of prophylactic value?M Verstraete
Pageof 42

Showing results (61-70 of 414) with videos related to

Sort By:
Pageof 42
British Medical Bulletin|October 1, 1994
Primary and secondary prevention of arterial thromboembolismM Verstraete
The American Journal of Medicine|December 1, 1976
Are agents affecting platelet functions clinically useful?M Verstraete
Coronary Artery Disease|April 1, 1994
Thrombolysis for arterial conditions other than myocardial infarctionM Verstraete
Thrombosis and Haemostasis|August 31, 1976
Registry of prospective clinical trials second reportM Verstraete
Acta Clinica Belgica|January 1, 1976
Are agents affecting platelet function clinically useful in patients with coronary artery disease?M Verstraete
Journal of Interventional Cardiology|November 4, 1995
Trials of the European Working Party on streptokinase and of the European Cooperative Study Group on alteplase in patients with acute myocardial infarction. European InvestigatorsM Verstraete
Lancet (London, England)|June 2, 2001
Exit of platelet glycoprotein-IIb/IIIa-receptor inhibitors?M Verstraete
Thrombosis Et Diathesis Haemorrhagica|June 30, 1975
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trialsM Verstraete
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1992
[European vision]M Verstraete
Drugs|June 1, 1978
Antiplatelet agents in coronary disease: are they of prophylactic value?M Verstraete
Pageof 42